Zevra Therapeutics Net Non-Operating Interest Income Expense (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

9.03 +0.01 (+0.11%) USD | NASDAQ | Jan 21, 16:00

9.03 0.00 (0.00%) After-Hours: 18:38

View Net Non-Operating Interest Income Expense (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

XOMA Royalty Corp.	Upgrade
Verastem, Inc.	Upgrade
ADMA Biologics, Inc.	Upgrade
Akebia Therapeutics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade